Boston & New England CRE News In Your Inbox.

Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.

Sub Markets

Property Sectors

Topics

Boston & New England  + Industrial  | 

$180M Life Sciences Facility Slated for Plainville

Thermo Fisher Scientific Inc. plans to build a new commercial manufacturing site in Plainville, MA. The $180-million project will more than double the company’s commercial viral vector capacity to support increasing demand for the development and manufacture of gene therapies and vaccines.

Construction of the new 290,000-square-foot facility is expected to be completed in 2022. The project will add more than 200 jobs and complement the company’s new or recently expanded capacity in Lexington and Cambridge, MA and Alachua, FL.

Headquartered in Waltham, MA, Thermo Fisher strategically selected Plainville to capitalize on its expertise at other Massachusetts locations and draw upon the strong talent pool in the Greater Boston area. The new facility will feature digital connectivity and capabilities that enable operational efficiencies, high quality, data visibility and advanced operator training.

Get CRE News in 150 words

For comments, questions or concerns, please contact Paul Bubny

Connect

Inside The Story

Connect With Thermo Fisher

About Paul Bubny

Paul Bubny serves as Senior Content Director for Connect Commercial Real Estate, a role to which he brings 13-plus years’ experience covering the commercial real estate industry and 30-plus years in business-to-business journalism. In this capacity, he oversees daily operations while also reporting on both local/regional markets and national trends, covering individual transactions across all property types, as well as delving into broader subject matter. He produces 15-20 daily news stories per day and works with the Connect team and clients to develop longer-form content, ranging from Q&As to thought-leadership pieces. Prior to joining Connect, Paul was Managing Editor for both Real Estate Forum and GlobeSt.com at American Lawyer Media, where he oversaw operations at both publications while also producing daily news and feature-length articles. His tenure in B2B publishing stretches back into the print era, and he has served as Editor in Chief on four national trade publications. Since 1999, Paul has volunteered as the newsletter editor of passenger rail advocacy groups (one national, one local).